The Rational Development of CD133-Targeting Immunotherapies for Glioblastoma.
Cell Stem Cell. 2020 Jun 4;26(6):832-844.e6. doi: 10.1016/j.stem.2020.04.008. Epub 2020 May 27.
Cell Stem Cell. 2020.
PMID: 32464096
Free article.